Patents by Inventor Eric Solis

Eric Solis has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 12433880
    Abstract: The present disclosure provides compounds and methods useful in the treatment of neurological disorders. The compounds of the invention, alone or in combination with other pharmaceutically active agents, can be used for treating or preventing neurological disorders.
    Type: Grant
    Filed: April 9, 2021
    Date of Patent: October 7, 2025
    Assignee: JANSSEN PHARMACEUTICA NV
    Inventors: Benjamin Matteson Vincent, Daniel Forrest Tardiff, Jeff Scott Piotrowski, Eric Solis, Robert Hughie Scannevin, Chee-Yeun Chung, Rebecca Aron, Bertrand Le Bourdonnec, Matthew Lucas, Kenneth Rhodes
  • Publication number: 20250304569
    Abstract: The present invention features compounds useful in the treatment of neurological disorders. The compounds of the invention, alone or in combination with other pharmaceutically active agents, can be used for treating or preventing neurological disorders.
    Type: Application
    Filed: April 14, 2025
    Publication date: October 2, 2025
    Applicant: JANSSEN PHARMACEUTICA NV
    Inventors: Matthew Lucas, Bertrand Le Bourdonnec, Iwona Wrona, Bhaumik Pandya, Parcharee Tivitmahaisoon, Kerem Ozboya, Benjamin Vincent, Daniel Tardiff, Jeff Piotrowski, Eric Solis, Robert Scannevin, Chee-Yeun Chung, Rebecca Aron, Kenneth Rhodes
  • Patent number: 12275723
    Abstract: The present invention features compounds useful in the treatment of neurological disorders. The compounds of the invention, alone or in combination with other pharmaceutically active agents, can be used for treating or preventing neurological disorders.
    Type: Grant
    Filed: September 27, 2023
    Date of Patent: April 15, 2025
    Assignee: JANSSEN PHARMACEUTICA NV
    Inventors: Matthew Lucas, Bertrand Le Bourdonnec, Iwona Wrona, Bhaumik Pandya, Parcharee Tivitmahaisoon, Kerem Ozboya, Benjamin Vincent, Daniel Tardiff, Jeff Piotrowski, Eric Solis, Robert Scannevin, Chee-Yeun Chung, Rebecca Aron, Kenneth Rhodes
  • Publication number: 20240124435
    Abstract: The present invention features compounds useful in the treatment of neurological disorders. The compounds of the invention, alone or in combination with other pharmaceutically active agents, can be used for treating or preventing neurological disorders.
    Type: Application
    Filed: September 27, 2023
    Publication date: April 18, 2024
    Applicant: JANSSEN PHARMACEUTICA NV
    Inventors: Matthew Lucas, Bertrand Le Bourdonnec, Iwona Wrona, Bhaumik Pandya, Parcharee Tivitmahaisoon, Kerem Ozboya, Benjamin Vincent, Daniel Tardiff, Jeff Piotrowski, Eric Solis, Robert Scannevin, Chee-Yeun Chung, Rebecca Aron, Kenneth Rhodes
  • Patent number: 11873298
    Abstract: The present invention features compounds useful in the treatment of neurological disorders. The compounds of the invention, alone or in combination with other pharmaceutically active agents, can be used for treating or preventing neurological disorders.
    Type: Grant
    Filed: October 24, 2018
    Date of Patent: January 16, 2024
    Assignee: JANSSEN PHARMACEUTICA NV
    Inventors: Matthew Lucas, Bertrand Le Bourdonnec, Iwona Wrona, Bhaumik Pandya, Parcharee Tivitmahaisoon, Kerem Ozboya, Benjamin Vincent, Daniel Tardiff, Jeff Piotrowski, Eric Solis, Robert Scannevin, Chee-Yeun Chung, Rebecca Aron, Kenneth Rhodes
  • Publication number: 20220230237
    Abstract: A method of enabling secure credit push transactions from a first financial institution to a second financial institution includes generating a credential that includes a bank routing number of the second financial institution and an account number of an account held at the second financial institution, receiving a selection of the first financial institution over a graphical user interface operated by the second financial institution, and, in response to the selection of the first financial institution, prompting a user of the graphical user interface to input login information for accessing an online account associated with the first financial institution. The method may further include, in response to the input of the login information, pushing the credential to a server operated by the first financial institution to be stored in an external account module of the first financial institution.
    Type: Application
    Filed: January 13, 2022
    Publication date: July 21, 2022
    Inventor: Eric Solis
  • Publication number: 20220040167
    Abstract: The present disclosure provides compounds and methods useful in the treatment of neurological disorders. The compounds of the invention, alone or in combination with other pharmaceutically active agents, can be used for treating or preventing neurological disorders.
    Type: Application
    Filed: April 9, 2021
    Publication date: February 10, 2022
    Inventors: Benjamin Matteson VINCENT, Daniel Forrest TARDIFF, Jeff Scott PIOTROWSKI, Eric SOLIS, Robert Hughie SCANNEVIN, Chee-Yeun CHUNG, Rebecca ARON, Bertrand LE BOURDONNEC, Matthew LUCAS, Kenneth RHODES
  • Patent number: 10973810
    Abstract: The present disclosure provides compounds and methods useful in the treatment of neurological disorders. The compounds of the invention, alone or in combination with other pharmaceutically active agents, can be used for treating or preventing neurological disorders.
    Type: Grant
    Filed: January 5, 2018
    Date of Patent: April 13, 2021
    Assignee: Yumanity Therapeutics, Inc.
    Inventors: Benjamin Vincent, Daniel Tardiff, Jeff Piotrowski, Eric Solis, Robert Scannevin, Chee-Yeun Chung, Rebecca Aron, Bertrand Le Bourdonnec, Matthew Lucas, Kenneth Rhodes
  • Publication number: 20200262828
    Abstract: The present invention features compounds useful in the treatment of neurological disorders. The compounds of the invention, alone or in combination with other pharmaceutically active agents, can be used for treating or preventing neurological disorders.
    Type: Application
    Filed: October 24, 2018
    Publication date: August 20, 2020
    Inventors: Matthew LUCAS, Bertrand LE BOURDONNEC, Iwona WRONA, Bhaumik PANDYA, Parcharee TIVITMAHAISOON, Kerem OZBOYA, Benjamin VINCENT, Daniel TARDIFF, Jeff PIOTROWSKI, Eric SOLIS, Robert SCANNEVIN, Chee-Yeun CHUNG, Rebecca ARON, Kenneth RHODES
  • Publication number: 20200010462
    Abstract: The present invention features compounds useful in the treatment of neurological disorders. The compounds of the invention, alone or in combination with other pharmaceutically active agents, can be used for treating or preventing neurological disorders.
    Type: Application
    Filed: October 24, 2017
    Publication date: January 9, 2020
    Inventors: Matthew LUCAS, Bertrand LE BOURDONNEC, Iwona WRONA, Bhaumik PANDYA, Parcharee TIVITMAHAISOON, Kerem OZBOYA, Benjamin VINCENT, Daniel TARDIFF, Jeff PIOTROWSKI, Eric SOLIS, Robert SCANNEVIN, Chee-Yeun CHUNG, Rebecca ARON, Kenneth Rhodes
  • Publication number: 20180193325
    Abstract: The present disclosure provides compounds and methods useful in the treatment of neurological disorders. The compounds of the invention, alone or in combination with other pharmaceutically active agents, can be used for treating or preventing neurological disorders.
    Type: Application
    Filed: January 5, 2018
    Publication date: July 12, 2018
    Inventors: Benjamin VINCENT, Daniel TARDIFF, Jeff PIOTROWSKI, Eric SOLIS, Robert SCANNEVIN, Chee-Yeun CHUNG, Rebecca ARON, Bertrand LE BOURDONNEC, Matthew LUCAS, Kenneth RHODES
  • Publication number: 20130159189
    Abstract: An automated method and system for managing Native American land trust rights is described. Login information may be received from a participant. An account record associated with the participant may be accessed to identify one or more land trust rights held by the participant. An offer to purchase at least one land trust right of the one or more land trust rights held by the participant may be made. An input from the participant accepting or rejecting the offer to purchase may be received. Upon acceptance of the offer, payment may be disbursed to the participant in accordance with the offer to purchase and account record associated with the participant may be updated to reflect a sale of the at least one land trust right.
    Type: Application
    Filed: December 20, 2012
    Publication date: June 20, 2013
    Applicant: JH Portfolio Debt Equities LLC
    Inventor: Eric Solis
  • Patent number: D431061
    Type: Grant
    Filed: July 1, 1999
    Date of Patent: September 19, 2000
    Inventor: Eric Solis